Home » Faculty »  Vascular Surgery »  Jade S. Hiramoto, M.D.

Jade S. Hiramoto, M.D.

Associate Professor of Surgery
Division of Vascular and Endovascular Surgery

Contact Information

Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-6110
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
  • 1984-88, North High School, Diploma
  • 1988-92, University of California, Los Angeles, B.Sc. (HON), Molecular, Cellular, and Developmental Biology
  • 1992-96, University of California, San Francisco School of Medicine, M.D.
  • 1996-97, University of California, San Francisco, Intern, General Surgery
  • 1997-02, University of California, San Francisco, Resident, General Surgery
  • 2002-03, University of California, San Francisco, Chief Resident, General Surgery
  • 2003-04, University of California, San Francisco, Fellow, Interventional Radiology
  • 2004-05, University of California, San Francisco, Fellow, Vascular Surgery
  • 2005-06, University of California, San Francisco Dept. of Epidemiology and Biostatistics, Postdoctoral Fellow, Clinical Research
  • American Board of Surgery
  • American Board of Surgery, Vascular Surgery
  • Carotid artery disease
  • Lower extremity arterial and venous disorders
  • Renovascular disease
  • Thoracic and abdominal aortic aneurysms and dissections
  • Varicose veins
  • Venous insufficiency
  • Gender differences in vascular surgical outcomes
  • Hemodynamic changes after aortic stent-graft placement
  • Inflammatory response and kidney injury after complex endovascular procedures
  • Spinal perfusion after endovascular thoracoabdominal aortic aneurysm repair

Dr. Jade Hiramoto is a vascular surgeon with expertise in both minimally invasive endovascular techniques as well as open surgical interventions. Her clinical areas of expertise include open and endovascular repair of thoracic and abdominal aortic aneurysms and dissections, carotid artery disease, renovascular disease, and lower extremity arterial and venous disorders.

 

Dr. Hiramoto earned her medical degree from the University of California, San Francisco School of Medicine. She completed her residency in general surgery, as well as fellowships in both interventional radiology and vascular surgery at the University of California San Francisco. She is an assistant professor of surgery at UCSF.

Dr. Hiramoto's research involves both clinical and translational research, with a special interest in the abnormal inflammatory response and kidney injury after complex endovascular aortic procedures. She is also interested in gender-based differences in the treatment and outcomes of vascular disease. Dr. Hiramoto is an investigator on several clinical trials, including the use of endovascular stent-grafts for treatment of abdominal and thoracic aortic aneurysms, the use of carotid stents for prevention of stroke, and the measurement of pressure changes in the aorta after placement of stent-grafts to treat aneurysms.

 
Most recent publications from a total of 49
  1. Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease. Vasc Endovascular Surg. 2015 Jul 5. View in PubMed
  2. Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. Ann Vasc Surg. 2015 Apr; 29(3):534-42. View in PubMed
  3. Premprabha D, Sobel J, Pua C, Chong K, Reilly LM, Chuter TA, Hiramoto JS. Visceral branch occlusion following aneurysm repair using multibranched thoracoabdominal stent-grafts. J Endovasc Ther. 2014 Dec; 21(6):783-90. View in PubMed
  4. Sobel JD, Vartanian SM, Gasper WJ, Hiramoto JS, Chuter TA, Reilly LM. Lower extremity weakness after endovascular aneurysm repair with multibranched thoracoabdominal stent grafts. J Vasc Surg. 2015 Mar; 61(3):623-9. View in PubMed
  5. Grenon SM, Cohen BE, Smolderen K, Vittinghoff E, Whooley MA, Hiramoto J. Peripheral arterial disease, gender, and depression in the Heart and Soul Study. J Vasc Surg. 2014 Aug; 60(2):396-403. View in PubMed
  6. Hiramoto JS, Katz R, Weisman S, Conte M. Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc. 2014; 3(2):e000651. View in PubMed
  7. Walker JP, Hiramoto JS, Gasper WJ, Auyang P, Conte MS, Rapp JH, Lovett DH, Owens CD. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease. J Vasc Surg. 2014 Jul; 60(1):176-83. View in PubMed
  8. Grenon SM, Chong K, Alley H, Nosova E, Gasper W, Hiramoto J, Boscardin WJ, Owens CD. Walking disability in patients with peripheral artery disease is associated with arterial endothelial function. J Vasc Surg. 2014 Apr; 59(4):1025-34. View in PubMed
  9. Garimella PS, Ix JH, Katz R, Chonchol MB, Kestenbaum BR, de Boer IH, Siscovick DS, Shastri S, Hiramoto JS, Shlipak MG, Sarnak MJ. Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study. Atherosclerosis. 2014 Mar; 233(1):91-6. View in PubMed
  10. Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg. 2013 Dec; 58(6):1525-31. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Jade S. Hiramoto, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X